. A pATOM36 RNAi cell line allowing simultaneous tetinducible expression of Ty1-tagged mHSP70 was produced. The cell line was induced for the indicated time points and total cellular extracts were analyzed by immunoblots using anti-Ty1 tag antibodies. The position of precursor and mature forms of Ty1-tagged mHsp70 are indicated.
Supplementary
. HA-tagged pATOM36 is fully functional. A. Schematic drawing of the pATOM36 loci in wildtype cells and after homologous recombination replacing one or both of the wildtype genes by variants of the pATOM36 gene that encode for HA-tagged proteins. Transgenic cell lines were selected for using puromycine (for the heterozygous cell line: pATOM36-HA Puro ) and a combination of puromycine and neomycine (for the homozygous cell line: pATOM36-HA Puro / pATOM36-HA Neo ), respectively. The positions of the pATOM36 gene-specific sense primer (pATOM36_s), the puromycine resistance gene-specific antisense primer (Puro_as) and the neomycine resistance gene-specific antisense primer (Neo_as) that were used to analyze the integration events are indicated. The size of the expected PCR fragments is depicted at the bottom. B. Agarose gel of a PCR analysis of wildtype (427 wt), heterozygous (pATOM36-HA Puro ) and homozygous cell lines (pATOM36-HA Puro /pATOM36-HA Neo ) using the primers indicated at the bottom. Left panel, amplification of a fragment of the -tubulin gene demonstrating that similar amounts of DNA were analyzed in all three cell lines. The size of the bands in the middle and the right panels are as predicted and consistent with the genomic organizations depicted in A. C. Immunoblot analysis of digitonin extracted mitochondrial proteins from the 427 wt, the pATOM36-HA Puro and the pATOM36-HA Puro /pATOM36-HA Neo cell lines using antisera against the HA-tag (top panel) and pATOM36 (middle panel). In the homozygous HA-tagged cell line only the HA-tagged version of pATOM36 is present. The addition of the tag results in a significant mobility shift when compared to the untagged protein. The anti-pATOM36 antiserum was prepared against the C-terminal 12 amino acid of the protein and affinity purified on the peptide.
